A GCN1-independent activator of the kinase GCN2
Zhu, J.; Emanuelli, G.; Masson, G.; Vinciauskaite, V.; Willems, H.; Lim, A.; Brown, C. A.; Winpenny, D.; Clarke, M.; Gilley, R.; Preston, F.; Wilson, J.; Bader, A.; Rahman, T.; Chambers, J. E.; Skidmore, J.; Morrell, N.; Marciniak, S. J.
Show abstract
Mutations of EIF2AK4, which encodes the eIF2 kinase GCN2, cause a severe inherited form of pulmonary hypertension called pulmonary veno-occlusive disease (PVOD). Some pathogenic variants of GCN2 are amenable to pharmacological reactivation by low concentrations of ATP-pocket binding inhibitors. Kinase inhibition at modestly elevated concentrations limits the clinical utility of these drugs against PVOD. We therefore performed an in cellulo chemical screen for GCN2 activators and identified three structurally distinct compounds with low micromolar stimulatory activities. Unlike previously described GCN2 activators, one of these molecules activated GCN2 independently of GCN1. Modelling supported by structure activity screens suggested it binds within the ATP-pocket of GCN2, but unlike existing ligands does not protrude inward into the allosteric pocket or outward into the solvent. This overcomes a key requirement of other GCN2 activators.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Targeting the Protein-Protein Interaction Between the CDC37 Co-Chaperone and Client Kinases by an Allosteric RAF Dimer Breaker 95%
- Developing inhibitors of the guanosine triphosphate hydrolysis accelerating activity of Regulator of G protein Signaling-14 95%
- Development of a novel high-throughput screen for the identification of new inhibitors of protein S-acylation 95%
Similar papers in this journal
- PKIS Deep Dive Yields a Chemical Starting Point for Dark Kinases and a Cell Active BRSK2 Inhibitor 96%
- Identification and structural characterization of small-molecule inhibitors of PINK1 95%
- A screen of FDA-approved drugs identifies inhibitors of Protein Tyrosine Phosphatase 4A3 (PTP4A3 or PRL-3) 95%
Similar papers in this journal
- A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells 94%
- Development of an improved inhibitor of Lats kinases to promote regeneration of mammalian organs 94%
- Mutation in Abl kinase with altered drug binding kinetics indicates a novel mechanism of imatinib resistance 94%
Similar papers in this journal
- A subset of CB002 xanthine analogues bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53 94%
- A Back-Door Insights into the modulation of Src kinase activity by the polyamine spermidine 94%
- Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.